Ayala Pharmaceuticals Inc (AYLA)

NASDAQ
1.07
-0.18(-14.40%)
Pre Market
1.11
+0.04(+3.74%)
- Real-time Data
  • Volume:
    27,866
  • Day's Range:
    1.07 - 1.31
  • 52 wk Range:
    1.07 - 14.95

AYLA Overview

Prev. Close
1.25
Day's Range
1.07-1.31
Revenue
2.99M
Open
1.31
52 wk Range
1.07-14.95
EPS
-2.74
Volume
27,866
Market Cap
14.95M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
56,279
P/E Ratio
-
Beta
-
1-Year Change
-90.17%
Shares Outstanding
13,972,778
Next Earnings Date
Aug 18, 2022
What is your sentiment on Ayala Pharma?
or
Market is currently closed. Voting is open during market hours.

Ayala Pharmaceuticals Inc Company Profile

Ayala Pharmaceuticals Inc Company Profile

Employees
35

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company’s lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • This stock is quite bullish and with little volume, it will soon skyrocket
    1
    • +12
      0